Concepedia

Philippe Brudi

PB

Statistics

Publications

39

Citations

3.2K

H-Index

21

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Stiftung Institut für Herzinfarktforschung

Klinikum Ludwigshafen

IPPMed (Germany)

Mahlo (Germany)

Philippe Brudi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in lipid-lowering therapy, cardiovascular disease, and low-density lipoprotein cholesterol lowering.

ORCID

Publications per year

1997–2019

39

Publications

39

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Anne B. Rossebø, Terje R. Pedersen, Kurt Boman et al. · New England Journal of Medicine · 2008 · 1.6K citations · Full text

, , +17

Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

Nikolaus Jander, Jan Minners, Ingar Holme et al. · Circulation · 2011 · 334 citations · Full text

, , +16

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II

Anselm K. Gitt, Dominik Lautsch, Jean Ferrières et al. · Atherosclerosis · 2017 · 148 citations

, , +17

Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients

Anselm K. Gitt, Dominik Lautsch, Jean Ferrières et al. · Atherosclerosis · 2016 · 110 citations

, , +11

Lipid‐altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Lawrence A. Leiter, D. J. Betteridge, Michel Farnier et al. · Diabetes Obesity and Metabolism · 2011 · 85 citations

, , +17

1–5 of 39